38560-28-0 Usage
Uses
Used in Organic Synthesis:
1-(3-Bromophenyl)azetidin-2-one is used as a building block for the synthesis of various biologically active compounds. Its unique structure allows for the creation of diverse organic molecules with potential applications in different fields.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1-(3-Bromophenyl)azetidin-2-one is utilized as a precursor in the development of pharmaceutical drugs. Its structural features contribute to the design of new chemical entities with potential pharmacological properties, making it an interesting target for drug discovery and development.
Used in Pharmaceutical Drug Development:
1-(3-Bromophenyl)azetidin-2-one is used as a key intermediate in the synthesis of pharmaceutical drugs. Its presence in the molecular structure can influence the drug's activity, selectivity, and efficacy, thus playing a crucial role in the development of novel therapeutic agents.
Used in Research and Development:
1-(3-Bromophenyl)azetidin-2-one is also used in scientific research to explore its potential applications and properties further. Studies on 1-(3-Bromophenyl)azetidin-2-one can lead to a better understanding of its role in various chemical and biological processes, opening up new avenues for its use in different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 38560-28-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,5,6 and 0 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 38560-28:
(7*3)+(6*8)+(5*5)+(4*6)+(3*0)+(2*2)+(1*8)=130
130 % 10 = 0
So 38560-28-0 is a valid CAS Registry Number.
38560-28-0Relevant academic research and scientific papers
Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
-
Page/Page column 55, (2008/06/13)
Compounds that are antagonists of the VR1 receptor, having formula (I) [image] or a pharmaceutically acceptable salt, prodrug, or salt of a prodrug thereof, wherein A1, A2, A3, A4, R7, R8, R9, X, Y, Z, L, n, and m, are as defined herein, and are useful in disorders prevented or ameliorated by inhibiting the VR1 receptor.
